VEEV NYSE Week ended 31 Jul 2026

Weekly Investor Report

Veeva Systems Inc Class A · Healthcare · Health Information Services

Latest close 203.8 USD
9.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 12.2% above the Trend Line and sits at 34.3% of its 52-week range. The latest completed week returned 9.4%, after a 5.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is bullish with 38/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 25d.

Setup score 36 out of 100
Latest Close 203.8 USD 31 Jul 2026
1W Return 9.4% latest completed week
4W Return 5.7% short-term follow-through
12W Return 22.5% quarterly tape
Trend Breadth 30.8% 16 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 12.2% above the Trend Line and sits at 34.3% of its 52-week range. The latest completed week returned 9.4%, after a 5.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1312-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 5.7% over four weeks, 22.5% over 12 weeks, and -27.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W9.4%
4W5.7%
12W22.5%
26W-0.1%
52W-27.6%
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.27Latest activity-pressure read.
Pressure change121.2%Four-week change in activity pressure.
Leadership-14.95Latest relative-leadership reading.
RS change34.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality95/100Profitability and accounting quality. Underlying universe rank 6; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework36/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
32.1x
Price divided by trailing earnings.
Price / sales
9.1x
Market value relative to trailing revenue.
EV / EBITDA
21.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.0%
Gross profit retained from each unit of revenue.
Operating margin
37.5%
Operating profit retained from revenue.
Free-cash-flow margin
50.8%
Free cash flow generated from revenue.
Return on invested capital
17.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
16.2%
Latest one-year revenue growth.
EPS growth
20.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
38.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

VEEV shows bullish options pressure with a 38/100 conviction score, put-call volume ratio of 0.74, expected move of 13.1%, and Sharemaestro trend signal inactive.

Conviction38/100
Expected move13.1%
Put/call volume0.74
Pressure21
Speculation42
Volatility75
Trend agreement46
Open options detail
Insider activity10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment52/100

Weighted news tone is neutral across 53 relevant articles.

13 positive · 34 neutral · 6 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings25dNext report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
Options expected move13.1%Nearest-chain priced movement where available.
52-week drawdown-34.4%Distance below the 52-week high.
13-week volatility6.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+12.5%Week of 3 Jul.
Worst week-13.0%Week of 10 Apr.
Latest week+9.4%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains6
Flat weeks0
Modest losses4
Sharp losses9
Recent vol6.6%13-week weekly-return volatility.
Base vol6.1%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.3% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026203.8 USD9.4%181.7 USD217.1 USD1.27-14.958.8MOff
24 Jul 2026186.2 USD-4.7%182.2 USD217.0 USD1.24-22.285.8MOff
17 Jul 2026195.4 USD2.8%183.5 USD217.1 USD1.20-19.937.8MOff
10 Jul 2026190.1 USD-1.4%184.4 USD217.2 USD0.88-24.148.9MOff
3 Jul 2026192.7 USD12.5%185.5 USD217.3 USD0.57-22.9211.7MOff
26 Jun 2026171.4 USD11.8%187.1 USD217.3 USD0.48-30.7815.4MOff
19 Jun 2026153.3 USD-3.9%189.4 USD217.5 USD0.43-40.3311.6MOff
12 Jun 2026159.5 USD-7.6%192.4 USD217.8 USD0.46-38.2610.1MOff
5 Jun 2026172.6 USD-1.0%196.9 USD218.0 USD0.47-33.7820.0MOff
29 May 2026174.3 USD8.8%201.0 USD218.1 USD0.39-35.6611.5MOff
22 May 2026160.2 USD0.8%204.9 USD218.2 USD0.28-40.8210.9MOff
15 May 2026158.9 USD-4.5%209.3 USD218.3 USD0.09-41.3910.2MOff
8 May 2026166.3 USD-3.1%213.5 USD218.3 USD-0.05-39.1451.0MOff
1 May 2026171.6 USD6.5%217.5 USD218.4 USD-0.35-36.3914.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.